| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 48.20B | $ 48.30B | $ 45.01B | $ 46.16B | $ 46.38B |
| Gross Profit | $ 34.26B | $ 27.43B | $ 25.36B | $ 26.49B | $ 26.76B |
| Operating Income | $ 13.72B | $ 9.66B | $ 8.47B | $ 9.27B | $ 9.54B |
| EBITDA | $ 15.23B | $ 3.17B | $ 19.37B | $ 19.22B | $ 20.12B |
| Net Income | $ 7.05B | $ -8.95B | $ 8.03B | $ 6.33B | $ 6.99B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 10.67B | $ 10.86B | $ 12.28B | $ 9.25B | $ 17.22B |
| Total Assets | $ 90.04B | $ 92.60B | $ 95.16B | $ 96.82B | $ 109.31B |
| Total Debt | $ 47.14B | $ 51.20B | $ 41.46B | $ 40.72B | $ 45.60B |
| Net Debt | $ 36.93B | $ 40.85B | $ 30.00B | $ 31.59B | $ 31.62B |
| Total Liabilities | $ 71.53B | $ 76.22B | $ 65.67B | $ 65.70B | $ 73.31B |
| Stockholders' Equity | $ 18.47B | $ 16.34B | $ 29.43B | $ 31.06B | $ 35.95B |
| Cash Flow | |||||
| Free Cash Flow | $ 12.85B | $ 13.94B | $ 12.65B | $ 11.95B | $ 15.23B |
| Operating Cash Flow | $ 14.16B | $ 15.19B | $ 13.86B | $ 13.07B | $ 16.21B |
| Investing Cash Flow | $ -4.13B | $ -21.35B | $ -2.29B | $ -1.06B | $ -538.00M |
| Financing Cash Flow | $ -10.35B | $ 5.13B | $ -9.42B | $ -16.96B | $ -16.22B |
Bristol-Myers Squibb (CH:BMY)
:BMY
